Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Knowing what to look for when reviewing a financial plan is essential. Discover the key factors that can impact your financial success.
23,752 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Three BDCs flash double-digit yields, but sustainability varies. FSK and SCM face earnings pressure and dividend cuts...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
SkyX’s Q1 2026 results hint at a company in transition: solid top-line momentum paired with ongoing investments. This...
Two popular aerospace ETFs, XAR and ITA, offer different paths to exposure in a sector shaped by defense spending and...
BitMine is tapping an established finance model to raise money for Ethereum buys. This article breaks down how a 9.5%...
Policy headwinds aren’t the end of the story for solar investors. This guide explains how AI-driven demand, select co...
Bitcoin prices have fallen from their peak while on-chain activity climbs. This article breaks down what rising activ...
A renewed wave of active investors is reshaping the discount broker scene. Charles Schwab stands out, quietly convert...
AI chips are reshaping tech, and ARM Holdings could ride the wave as a major royalty player. This article explains wh...
Before you lend or invest, you need a clear view of the market. This guide covers four practical metrics to analyze a...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...